SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001213900-20-037984
Filing Date
2020-11-18
Accepted
2020-11-18 16:28:38
Documents
3

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea129994-13dfeld_180life.htm SC 13D 61051
2 LOCK-UP AGREEMENT, DATED DECEMBER 19, 2019 ea129994ex99-1_180life.htm EX-99.1 33566
3 GRAPHIC exa_001.jpg GRAPHIC 14420
  Complete submission text file 0001213900-20-037984.txt   110504
Mailing Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019
Business Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019 212-319-5555
180 Life Sciences Corp. (Subject) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90013 | Film No.: 201325461
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 DURHAM TERRACE LONDON X0 W25PB
Business Address
Feldmann Marc (Filed by) CIK: 0001832327 (see all company filings)

Type: SC 13D